125 related articles for article (PubMed ID: 9524765)
1. Domain structure of hepatocyte growth factor/scatter factor (HGF/SF).
Gherardi E; Hartmann G; Hepple J; Chirgadze D; Srinivasan N; Blundell T
Ciba Found Symp; 1997; 212():84-93; discussion 93-104. PubMed ID: 9524765
[TBL] [Abstract][Full Text] [Related]
2. Insights into the structure of hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation.
Chirgadze DY; Hepple J; Byrd RA; Sowdhamini R; Blundell TL; Gherardi E
FEBS Lett; 1998 Jun; 430(1-2):126-9. PubMed ID: 9678607
[TBL] [Abstract][Full Text] [Related]
3. Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains.
Holmes O; Pillozzi S; Deakin JA; Carafoli F; Kemp L; Butler PJ; Lyon M; Gherardi E
J Mol Biol; 2007 Mar; 367(2):395-408. PubMed ID: 17258232
[TBL] [Abstract][Full Text] [Related]
4. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
Donate LE; Gherardi E; Srinivasan N; Sowdhamini R; Aparicio S; Blundell TL
Protein Sci; 1994 Dec; 3(12):2378-94. PubMed ID: 7756992
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis.
Montesano R; Soriano JV; Malinda KM; Ponce ML; Bafico A; Kleinman HK; Bottaro DP; Aaronson SA
Cell Growth Differ; 1998 May; 9(5):355-65. PubMed ID: 9607557
[TBL] [Abstract][Full Text] [Related]
6. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor.
Mizuno K; Inoue H; Hagiya M; Shimizu S; Nose T; Shimohigashi Y; Nakamura T
J Biol Chem; 1994 Jan; 269(2):1131-6. PubMed ID: 8288571
[TBL] [Abstract][Full Text] [Related]
7. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo.
Hartmann G; Prospero T; Brinkmann V; Ozcelik C; Winter G; Hepple J; Batley S; Bladt F; Sachs M; Birchmeier C; Birchmeier W; Gherardi E
Curr Biol; 1998 Jan; 8(3):125-34. PubMed ID: 9443912
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis and molecular modeling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid side chains important for interaction with the c-Met receptor.
Lokker NA; Presta LG; Godowski PJ
Protein Eng; 1994 Jul; 7(7):895-903. PubMed ID: 7971951
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution.
Ultsch M; Lokker NA; Godowski PJ; de Vos AM
Structure; 1998 Nov; 6(11):1383-93. PubMed ID: 9817840
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.
Lietha D; Chirgadze DY; Mulloy B; Blundell TL; Gherardi E
EMBO J; 2001 Oct; 20(20):5543-55. PubMed ID: 11597998
[TBL] [Abstract][Full Text] [Related]
11. Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa.
Pediaditakis P; Monga SP; Mars WM; Michalopoulos GK
J Biol Chem; 2002 Apr; 277(16):14109-15. PubMed ID: 11832492
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for agonism and antagonism of hepatocyte growth factor.
Tolbert WD; Daugherty-Holtrop J; Gherardi E; Vande Woude G; Xu HE
Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13264-9. PubMed ID: 20624990
[TBL] [Abstract][Full Text] [Related]
13. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.
Hartmann G; Naldini L; Weidner KM; Sachs M; Vigna E; Comoglio PM; Birchmeier W
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11574-8. PubMed ID: 1280830
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of hepatocyte growth factor/scatter factor and MET signalling.
Gherardi E; Sandin S; Petoukhov MV; Finch J; Youles ME; Ofverstedt LG; Miguel RN; Blundell TL; Vande Woude GF; Skoglund U; Svergun DI
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4046-51. PubMed ID: 16537482
[TBL] [Abstract][Full Text] [Related]
15. Engineering the NK1 fragment of hepatocyte growth factor/scatter factor as a MET receptor antagonist.
Youles M; Holmes O; Petoukhov MV; Nessen MA; Stivala S; Svergun DI; Gherardi E
J Mol Biol; 2008 Mar; 377(3):616-22. PubMed ID: 18291418
[TBL] [Abstract][Full Text] [Related]
16. The N-terminal domain of hepatocyte growth factor inhibits the angiogenic behavior of endothelial cells independently from binding to the c-met receptor.
Merkulova-Rainon T; England P; Ding S; Demerens C; Tobelem G
J Biol Chem; 2003 Sep; 278(39):37400-8. PubMed ID: 12847110
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
Recio JA; Merlino G
Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
[TBL] [Abstract][Full Text] [Related]
18. Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent MET receptor agonist.
de Nola G; Leclercq B; Mougel A; Taront S; Simonneau C; Forneris F; Adriaenssens E; Drobecq H; Iamele L; Dubuquoy L; Melnyk O; Gherardi E; de Jonge H; Vicogne J
Life Sci Alliance; 2022 Jul; 5(12):. PubMed ID: 35905995
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding.
Chirgadze DY; Hepple JP; Zhou H; Byrd RA; Blundell TL; Gherardi E
Nat Struct Biol; 1999 Jan; 6(1):72-9. PubMed ID: 9886295
[TBL] [Abstract][Full Text] [Related]
20. Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor.
Gherardi E; Youles ME; Miguel RN; Blundell TL; Iamele L; Gough J; Bandyopadhyay A; Hartmann G; Butler PJ
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12039-44. PubMed ID: 14528000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
